fda warning compounded semaglutide safety 2024 2025 The has received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms., Patients should avoid compounded What Patients Need to Know

Phase 3 trials are still generating the data that regulators will need before any approval decision

Extended continuous use beyond 12 weeks may lead to diminishing returns as receptors downregulate

Aim for at least 100 grams of protein daily, spread across meals

The issue with restrained eating is that it requires a constant conscious effort

Though there has been some rudimentary research work indicating that the GLP-1 receptor agonists can indirectly provide mood-enhancing effects by regulating the dopamine reward system, lessening inflammatory responses, or improving metabolic status, adverse events that have been observed in real life studies and case reports can suggest that their action at the central nervous system is more complicated [11, 16, 17]